Background Antidepressant Drugs (ADs) are among the most commonly prescribed medications in developed countries. The available epidemiological evidence suggests an …
TW Ho, CT Huang, SY Ruan, YJ Tsai, F Lai, CJ Yu - PLoS One, 2017 - journals.plos.org
Background Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide. There is evidence to support a connection between …
Aims Depression and anxiety may increase the risk of progressing from prediabetes to type 2 diabetes. The present study examined the interactions between prediabetes status and …
Emerging evidence indicates that treatment context profoundly affects psychopharmacological interventions. We review the evidence for the interaction between …
M Burcu, JM Zito, DJ Safer, LS Magder… - JAMA …, 2017 - jamanetwork.com
Importance Antidepressants are one of the most commonly prescribed classes of psychotropic medications among US youths. For adults, there is emerging evidence on the …
Y Wang, D Liu, X Li, Y Liu, Y Wu - Journal of Affective Disorders, 2021 - Elsevier
Background This study aimed at examining the effects of different antidepressants on the new onset of T2DM. Methods Systematic literature retrieval for cohort and case-control …
HY Chen, HC Pan, YC Chen, YC Chen, YH Lin… - … and alternative medicine, 2019 - Springer
Background Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM) that imposes an enormous burden on the healthcare system. Although some studies show …
A Berhan, A Barker - BMC psychiatry, 2014 - Springer
Background Vortioxetine is a novel multimodal compound that has recently been approved by the FDA for the treatment of major depressive disorder (MDD). It is a selective serotonin …
Abstract Rationale Metabolic syndrome (MetS) is common in patients with bipolar disorder, with a relative risk of 1.6–2 compared to the general population. The increased risk is …